EUVIMEDEUVIMED entdecken
Crossref

Rectal nanoparticulate-hydrogel delivering budesonide to reduce enterohepatic drug metabolism and clearance

Rui Xue Zhang, Weijia Lu, Xu Yan, Xudong Deng, Runrun Wan, Zhejun Song, Jiayan Liang, Xue-Ting Wang, Tingting Cao, Yan Chen, Paul K H Tam

Drug Delivery and Translational Research · 2026-11 · 16 (11) · 4178-4197

DOI: 10.1007/s13346-026-02095-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 20.03.2026. Verfasst von Rui Xue Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Precision Regenerative Medicine Research Centre, Medical Sciences Division, Macau University of Science and Technology, Macau, China. zhangruixue@mus…. Hauptthemen laut MEDLINE: Budesonide, Hydrogels, Nanoparticles, Anti-Inflammatory Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Macau University of Science and Technology Faculty Research Grants, National Natural Science Foundation of China, Advanced Education Project of China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precise dosing is critical for effective therapeutics, yet extensive enterohepatic metabolism poses a major barrier to many orally administered small-molecule drugs. Budesonide, a potent corticosteroid for treating enterohepatic inflammation, undergoes significant first-pass metabolism by cytochrome P450 3A abundantly expressed in the liver and intestine, resulting in variable efficacy and unpredictable toxicity. Rectal drug delivery offers an alternative route that can reduce first-pass metabolism. This work aimed to alter enterohepatic metabolism and clearance of budesonide using a rectal nanoparticles-hydrogel system for localized drug delivery. Budesonide was encapsulated into nanostructured lipid carrier (BD-LNP), which were then entrapped in a dynamic boronate ester crosslinked hydrogel (BD-LNP@Hydrogel). The hydrogel network exhibited thermal and mechanical stability, maintaining a drug depot post-injection, while BD-LNP was released in a controlled manner upon hydrogel degradation in simulated colonic fluid. BD-LNP@Hydrogel achieved a permeability coefficient > 1 × 10-6 cm·s-1 across human intestinal epithelial monolayers, indicating completed absorption of budesonide. Compared to BD-LNP alone, BD-LNP@Hydrogel provided 4.3-fold higher nanoparticle exposure in the colonic lumen, enhancing intestinal uptake into deeper mucosal layer (e.g., lamina propria) over time. Pharmacokinetic analysis in mice revealed that rectal BD-LNP@Hydrogel markedly reduced formation of the budesonide metabolite 16α-hydroxyprednisolone compared to the oral route. Physiologically-based pharmacokinetic modeling confirmed preferential pharmacokinetics for rectal BD-LNP@Hydrogel over oral delivery, including up to 7.3-fold higher absorption rate constant, superior intestinal transport, and significantly reduced enterohepatic clearance of 16α-hydroxyprednisolone. These findings highlight the potential of nanoparticles-hydrogel systems for rectal delivery of drugs with extensive metabolism and provide mechanistic insight into achieving therapeutic precision via rectal delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BudesonideHydrogelsNanoparticlesAnti-Inflammatory AgentsAdministration, RectalAnimalsHumansMiceMaleDrug CarriersDrug LiberationIntestinal MucosaIntestinal Absorption

Stichwörter der Autor:innen

BudesonideFirst-Pass EffectGastrointestinal-Based Drug DeliveryMetabolitePKPB ModelPharmacokinetics

Substanzen

BudesonideHydrogelsAnti-Inflammatory AgentsDrug Carriers

Autor:innen und Institutionen

  • Precision Regenerative Medicine Research Centre, Medical Sciences Division, Macau University of Science and Technology, Macau, China. zhangruixue@must.edu.mo.
  • Faculty of Medicine, and School of Pharmacy, Medical Sciences Division, Macau University of Science and Technology, Macau, China. zhangruixue@must.edu.mo.
  • Institute of Medical Research, Northwestern Polytechnical University, 127 West Youyi Road, Xi'an, 710072, Shaanxi, China. zhangruixue@must.edu.mo.
  • Institute of Medical Research, Northwestern Polytechnical University, 127 West Youyi Road, Xi'an, 710072, Shaanxi, China.
  • School of Life Sciences, Northwestern Polytechnical University, 127 West Youyi Road, Xi'an, 710072, Shaanxi, China.
  • Precision Regenerative Medicine Research Centre, Medical Sciences Division, Macau University of Science and Technology, Macau, China.

Förderung

  • Macau University of Science and Technology Faculty Research Grants
  • National Natural Science Foundation of China
  • Advanced Education Project of China Scholarship Council
  • Fundamental Research Funds for Central Universities
  • Macau Science and Technology Development Fund
  • Scholarship of International Leadership Program

Zitieren

APA

Zhang, R. X., Lu, W., Yan, X., Deng, X., Wan, R., Song, Z., Liang, J., Wang, X. T., Cao, T., Chen, Y., & Tam, P. K. H. (2026). Rectal nanoparticulate-hydrogel delivering budesonide to reduce enterohepatic drug metabolism and clearance. Drug Delivery and Translational Research, 16(11), 4178-4197. https://doi.org/10.1007/s13346-026-02095-9

Vancouver

Zhang RX, Lu W, Yan X, Deng X, Wan R, Song Z, et al. Rectal nanoparticulate-hydrogel delivering budesonide to reduce enterohepatic drug metabolism and clearance. Drug Delivery and Translational Research. 2026;16(11):4178-4197. doi:10.1007/s13346-026-02095-9

BibTeX
@article{Zhang2026,
  author = {Zhang, Rui Xue and Lu, Weijia and Yan, Xu and Deng, Xudong and Wan, Runrun and Song, Zhejun and Liang, Jiayan and Wang, Xue-Ting and Cao, Tingting and Chen, Yan and Tam, Paul K H},
  title = {Rectal nanoparticulate-hydrogel delivering budesonide to reduce enterohepatic drug metabolism and clearance},
  journal = {Drug Delivery and Translational Research},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {4178--4197},
  doi = {10.1007/s13346-026-02095-9}
}
Kostenlos starten →